CD274 and neoplasm: With reference to immune evasion, Zhou et al. demonstrated that miR-424-5p delivery through AT-MSC-derived EVs partly exerted pro-inflammatory effects and enhanced anti-tumor cytotoxicity in human triple-negative breast cancer cells both in vitro and in vivo, through the downregulation of the PD-L1 pathway (Zhou et al., 2021).